Meetings-2008

GRS Meetings 2008

Meeting number	42
Date	10/14/2008
Topic	HIV accessory genes: in quest of essentiality
Organizer	Gianfranco Pancino
Speakers	Serge Bénichou Institut Cochin, Inserm U567, CNRS UMR8104, Paris Vpr: a player in the early steps of the viral replication cycle
	Andrea Cimarelli Ecole Normale Supérieure de Lyon, INSERM U758, LaboRetro, Human Virology Vpx role in the infection of myeloid cells
	Florence Margottin-Goguet Equipe AVENIR C3PV "Contrôle du Cycle Cellulaire et Proteines Virales", Institut Cochin, Paris How does the Vpu protein promote viral particle release?

Meeting number	41
Date	09/16/2008
Topic	Tregs in HIV infection
Organizer	Laurence Weiss
Speakers	Lisa Chakrabarti Unité d'Immunogénétique Cellulaire, Institut Pasteur, Paris Homeostatic regulation of Tregs: role of IL-2 and IL-7
	Claire Chougnet Cincinnati Children's Hospital Medical Center, USA Regulatory T cells in HIV infection: a complex balancing act
	Laurence Weiss Unité de Régulation des Infections Rétrovirales, Institut Pasteur, Paris Regulatory T cells and immune activation in HIV infected patients under efficient antiretroviral therapy and after 12 month treatment interruption: the ANRS 116 SALTO trial

Meeting number	40
Date	05/29/2008
Topic	HIV resistance to antiretroviral therapy
Organizer	Jacques Thèze
Speakers	Mark Wainberg McGill University, AIDS Center, Montreal, Canada Differences between HIV subtypes regarding resistance to therapy: consequences on public health and prevention programs

Meeting number	39
Date	05/29/2008
Topic	Immunotherapy of HIV infection
Organizer	Jacques Thèze
Speakers	Cliff Lane Director of Clinical Research, NIAID, NIH, Bethesda, USA IL-2, IL-7, and IL-15: the role of gamma-c cytokines as immune based therapies in HIV infection
Speakers	Irini Sereti NIAID, NIH, Bethesda, USA IL-2 and IL-7 in HIV infection: from bench to bedside and back

Meeting number	38
Date	04/10/2008
Topic	GMO plants and vaccines against HIV and HBV
Organizer	Gianfranco Pancino
Speakers	David Tepfer Physicochimie et Ecotoxicologie des Sols d'Agrosystèmes Contaminés (PESSAC), INRA, Versailles Plants and Biotechnology: How and Why
	Tomascz Pniewski Laboratory of Structural Genomics, Plant Genetics Institute, Polish Science Academy of Poznan, Poland Plant-derived new generation vaccine against Hepatitis B
	Monica Sala Unité de Rétrovirologie Moléculaire, Institut Pasteur, Paris An HIV-1 vaccine by oral administration of transgenic plants: a novel approach to vectorization

Meeting number	37
Date	03/18/2008
Topic	HIV integrase inhibitors
Organizer	Lisa Chakrabarti
Speakers	Jean-François Mouscadet CNRS UMR 8113, Ecole Normale Supérieure de Cachan, Cachan Introduction: the role of Integrase in the HIV life cycle
	Catherine Dargemont CNRS UMR 7592, Institut Jacques Monod, Paris HIV integrase cellular partners
	Jean-François Mouscadet CNRS UMR 8113, Ecole Normale Supérieure de Cachan, Cachan Mechanisms of action of integrase inhibitors
	Jade Ghosn Service de Médecine Interne et Maladies Infectieuses, Hôpital du Kremlin-Bicêtre Clinical use of integrase inhibitors

Meeting number	36
Date	01/22/2008
Topic	HIV and the Immune Reconstitution Inflammatory Syndrome: "In the eye of IRIS "
Organizer	Claudine Duvivier
Speakers	Guillaume Breton Service de Médecine Interne, Hôpital Pitié-Salpêtrière, Paris IRIS: from concept to practice
	Homa Adle Service d'Anatomopathologie de l'Hôpital Bichat-Claude Bernard, Paris Different IRIS forms in anatomopathology
	Anne Bourgarit Service de Médecine Interne, Hôpital Saint-Louis, INSERM U543, Paris Physiopathology of IRIS
	Bob Colebunders Institute of Tropical Medicine, Anvers University, Belgium IRIS in countries with limited resources